Oct 24, 2022
How Breast Centers Can Keep Up with Changing NCCN ...
Risk models and oncology guidelines are constantly being reviewed and updated as new evidence comes to light. It can be difficult for providers, who are managing a full slate of patients, to keep up to speed with these important changes, especially with the ...
Jun 27, 2022
4 Steps to Setting Up & Scaling Your Genetics ...
Our mission at CancerIQ is to help hospitals and health systems stay ahead of cancer by making precision prevention and early detection accessible to all patients. We know these organizations have a similar mission – but all too often, the realities of ...
Jun 14, 2022
Making the Business Case for Genomics
Genomics has an established benefit in precision cancer care for patients and providers alike – but its positive financial impact on your health system has untapped potential in prevention. As a tool for early detection, genomics can be a significant source ...
May 11, 2022
3 Paths to a Sustainable High-Risk Cancer Program
At the University of Chicago’s 10th Annual International Clinical Cancer Genetics & Genomics Conference last month, CancerIQ’s Chief Product Officer Haibo Lu and Vice President of Sales Matt Valin presented the challenges of high-risk cancer program ...
Oct 19, 2021
Making the Case for a High-Risk Breast Program
It’s an all-too-common scenario in today’s breast centers: A woman who comes in every year for her mammogram fills out an intake form to provide the health system with her family history. A few weeks later, she receives a letter in the mail saying that her ...
Jan 4, 2021
Top 5 Takeaways From President’s Cancer Panel on ...
In November, I attended the President’s Cancer Panel titled Improving Resilience and Equity in Cancer Screening: Lessons from COVID-19 and Beyond. This discussion series focused on screening across four cancer types: cervical, breast, lung and colorectal ...
Jul 1, 2020
Best Practices: Supporting a Safe Return to ...
As COVID-19 began spreading rapidly in the U.S., doctor’s offices and clinics closed in-person visits to lower the risk of spreading the virus. In response, the use of telehealth skyrocketed. A survey of cancer programs from the Advisory Board showed ...
Jun 1, 2020
Best Practices for Virtual Genetics & High-Risk ...
Cancer is now responsible for almost 1 in 6 deaths globally. More than 14 million people develop cancer every year, and this figure was projected to rise to over 21 million by 2030… before COVID-19 interrupted measures aiming to reduce cancer’s impact.
Apr 1, 2020
Why Your Genetics and High Risk Programs are ...
Three months ago, health systems were embracing precision health strategies, and capturing the full clinical and financial value of using genetics in routine care. That’s before COVID-19 forced every US health group to close their doors to most patients. ...
Content not found
